The use of urinary kidney injury molecule-1 and neutrophil gelatinase-associated lipocalin for diagnosis of hepato-renal syndrome in advanced cirrhotic patients

Background Chronic liver disease is a common and important clinical problem. Hepatorenal syndrome (HRS) is a life threatening complication. Serum creatinine (Cr) remains the only conventional indicator of renal function. However, the interpretation of serum Cr level can be confounded by malnutrition...

Full description

Saved in:
Bibliographic Details
Main Authors: Mohamed Adel Abd Elaziz, Asmaa Mustafa Gouda Elewa, Dina Zaki Mohamed Zaki Abdel Hamid, Nohier Essam Soliman Ahmed Hassan, Éva Csongrádi, Emad Hamdy Hamouda Mohammed, Mohammed Abdel Gawad
Format: Article
Language:English
Published: Taylor & Francis Group 2024-12-01
Series:Renal Failure
Subjects:
Online Access:https://www.tandfonline.com/doi/10.1080/0886022X.2024.2346284
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832591114280894464
author Mohamed Adel Abd Elaziz
Asmaa Mustafa Gouda Elewa
Dina Zaki Mohamed Zaki Abdel Hamid
Nohier Essam Soliman Ahmed Hassan
Éva Csongrádi
Emad Hamdy Hamouda Mohammed
Mohammed Abdel Gawad
author_facet Mohamed Adel Abd Elaziz
Asmaa Mustafa Gouda Elewa
Dina Zaki Mohamed Zaki Abdel Hamid
Nohier Essam Soliman Ahmed Hassan
Éva Csongrádi
Emad Hamdy Hamouda Mohammed
Mohammed Abdel Gawad
author_sort Mohamed Adel Abd Elaziz
collection DOAJ
description Background Chronic liver disease is a common and important clinical problem. Hepatorenal syndrome (HRS) is a life threatening complication. Serum creatinine (Cr) remains the only conventional indicator of renal function. However, the interpretation of serum Cr level can be confounded by malnutrition and reduced muscle mass often observed in patients with severe liver disease. Here, we present a cross-sectional study to explore the sensitivity and specificity of other markers as urinary KIM-1 and NGAL for cases of HRS.Methods Cross-sectional study was conducted on 88 patients who were admitted to Alexandria main university hospital. Enrolled patients were divided in two groups; group 1: patients with advanced liver cirrhosis (child B and C) who have normal kidney functions while group 2: patients who developed HRS. Stata© version 14.2 software package was used for analysis.Results Group 1 included 18 males and 26 females compared to 25 males and 19 females in group 2 (p = 0.135). Only the urinary KIM-1 showed a statistically significant difference between both groups in the multivariate logistic regression analysis adjusted for gender, serum bilirubin, serum albumin, INR, serum K, AST and ALT levels.Conclusion In conclusion, our study aligns with prior research, as seen in the consistent findings regarding Urinary NGAL elevation in cirrhotic patients with AKI. Urinary KIM-1, independent of Urinary NGAL, may have a role in precisely distinguishing between advanced liver cirrhosis and HRS and merits further exploration.
format Article
id doaj-art-93aab87571594a859b0d79880f0c3e95
institution Kabale University
issn 0886-022X
1525-6049
language English
publishDate 2024-12-01
publisher Taylor & Francis Group
record_format Article
series Renal Failure
spelling doaj-art-93aab87571594a859b0d79880f0c3e952025-01-23T04:17:48ZengTaylor & Francis GroupRenal Failure0886-022X1525-60492024-12-0146110.1080/0886022X.2024.2346284The use of urinary kidney injury molecule-1 and neutrophil gelatinase-associated lipocalin for diagnosis of hepato-renal syndrome in advanced cirrhotic patientsMohamed Adel Abd Elaziz0Asmaa Mustafa Gouda Elewa1Dina Zaki Mohamed Zaki Abdel Hamid2Nohier Essam Soliman Ahmed Hassan3Éva Csongrádi4Emad Hamdy Hamouda Mohammed5Mohammed Abdel Gawad6Tropical Medicine Department, Faculty of Medicine, Alexandria University, Alexandria, EgyptDepartment of Clinical and Chemical Pathology, Faculty of Medicine, Alexandria University, Alexandria, EgyptClinical Pharmacist at Alexandria Hepatology, Gastroenterology and Fever Hospital, EgyptClinical Pharmacist at Zamzam Hospital, Alexandria, EgyptFaculty of Medicine, University of Debrecen, Debrecen, HungaryLecturer of Critical Care, Faculty of Medicine, Alexandria University, Alexandria, EgyptNephrology Unit, Internal Medicine Department, School of Medicine, Newgiza (NGU) University, Giza, EgyptBackground Chronic liver disease is a common and important clinical problem. Hepatorenal syndrome (HRS) is a life threatening complication. Serum creatinine (Cr) remains the only conventional indicator of renal function. However, the interpretation of serum Cr level can be confounded by malnutrition and reduced muscle mass often observed in patients with severe liver disease. Here, we present a cross-sectional study to explore the sensitivity and specificity of other markers as urinary KIM-1 and NGAL for cases of HRS.Methods Cross-sectional study was conducted on 88 patients who were admitted to Alexandria main university hospital. Enrolled patients were divided in two groups; group 1: patients with advanced liver cirrhosis (child B and C) who have normal kidney functions while group 2: patients who developed HRS. Stata© version 14.2 software package was used for analysis.Results Group 1 included 18 males and 26 females compared to 25 males and 19 females in group 2 (p = 0.135). Only the urinary KIM-1 showed a statistically significant difference between both groups in the multivariate logistic regression analysis adjusted for gender, serum bilirubin, serum albumin, INR, serum K, AST and ALT levels.Conclusion In conclusion, our study aligns with prior research, as seen in the consistent findings regarding Urinary NGAL elevation in cirrhotic patients with AKI. Urinary KIM-1, independent of Urinary NGAL, may have a role in precisely distinguishing between advanced liver cirrhosis and HRS and merits further exploration.https://www.tandfonline.com/doi/10.1080/0886022X.2024.2346284Hepatorenal syndromeneutrophil gelatinase-associated lipocalinurinary kidney injury molecule-1serum creatinineliver cirrhosis
spellingShingle Mohamed Adel Abd Elaziz
Asmaa Mustafa Gouda Elewa
Dina Zaki Mohamed Zaki Abdel Hamid
Nohier Essam Soliman Ahmed Hassan
Éva Csongrádi
Emad Hamdy Hamouda Mohammed
Mohammed Abdel Gawad
The use of urinary kidney injury molecule-1 and neutrophil gelatinase-associated lipocalin for diagnosis of hepato-renal syndrome in advanced cirrhotic patients
Renal Failure
Hepatorenal syndrome
neutrophil gelatinase-associated lipocalin
urinary kidney injury molecule-1
serum creatinine
liver cirrhosis
title The use of urinary kidney injury molecule-1 and neutrophil gelatinase-associated lipocalin for diagnosis of hepato-renal syndrome in advanced cirrhotic patients
title_full The use of urinary kidney injury molecule-1 and neutrophil gelatinase-associated lipocalin for diagnosis of hepato-renal syndrome in advanced cirrhotic patients
title_fullStr The use of urinary kidney injury molecule-1 and neutrophil gelatinase-associated lipocalin for diagnosis of hepato-renal syndrome in advanced cirrhotic patients
title_full_unstemmed The use of urinary kidney injury molecule-1 and neutrophil gelatinase-associated lipocalin for diagnosis of hepato-renal syndrome in advanced cirrhotic patients
title_short The use of urinary kidney injury molecule-1 and neutrophil gelatinase-associated lipocalin for diagnosis of hepato-renal syndrome in advanced cirrhotic patients
title_sort use of urinary kidney injury molecule 1 and neutrophil gelatinase associated lipocalin for diagnosis of hepato renal syndrome in advanced cirrhotic patients
topic Hepatorenal syndrome
neutrophil gelatinase-associated lipocalin
urinary kidney injury molecule-1
serum creatinine
liver cirrhosis
url https://www.tandfonline.com/doi/10.1080/0886022X.2024.2346284
work_keys_str_mv AT mohamedadelabdelaziz theuseofurinarykidneyinjurymolecule1andneutrophilgelatinaseassociatedlipocalinfordiagnosisofhepatorenalsyndromeinadvancedcirrhoticpatients
AT asmaamustafagoudaelewa theuseofurinarykidneyinjurymolecule1andneutrophilgelatinaseassociatedlipocalinfordiagnosisofhepatorenalsyndromeinadvancedcirrhoticpatients
AT dinazakimohamedzakiabdelhamid theuseofurinarykidneyinjurymolecule1andneutrophilgelatinaseassociatedlipocalinfordiagnosisofhepatorenalsyndromeinadvancedcirrhoticpatients
AT nohieressamsolimanahmedhassan theuseofurinarykidneyinjurymolecule1andneutrophilgelatinaseassociatedlipocalinfordiagnosisofhepatorenalsyndromeinadvancedcirrhoticpatients
AT evacsongradi theuseofurinarykidneyinjurymolecule1andneutrophilgelatinaseassociatedlipocalinfordiagnosisofhepatorenalsyndromeinadvancedcirrhoticpatients
AT emadhamdyhamoudamohammed theuseofurinarykidneyinjurymolecule1andneutrophilgelatinaseassociatedlipocalinfordiagnosisofhepatorenalsyndromeinadvancedcirrhoticpatients
AT mohammedabdelgawad theuseofurinarykidneyinjurymolecule1andneutrophilgelatinaseassociatedlipocalinfordiagnosisofhepatorenalsyndromeinadvancedcirrhoticpatients
AT mohamedadelabdelaziz useofurinarykidneyinjurymolecule1andneutrophilgelatinaseassociatedlipocalinfordiagnosisofhepatorenalsyndromeinadvancedcirrhoticpatients
AT asmaamustafagoudaelewa useofurinarykidneyinjurymolecule1andneutrophilgelatinaseassociatedlipocalinfordiagnosisofhepatorenalsyndromeinadvancedcirrhoticpatients
AT dinazakimohamedzakiabdelhamid useofurinarykidneyinjurymolecule1andneutrophilgelatinaseassociatedlipocalinfordiagnosisofhepatorenalsyndromeinadvancedcirrhoticpatients
AT nohieressamsolimanahmedhassan useofurinarykidneyinjurymolecule1andneutrophilgelatinaseassociatedlipocalinfordiagnosisofhepatorenalsyndromeinadvancedcirrhoticpatients
AT evacsongradi useofurinarykidneyinjurymolecule1andneutrophilgelatinaseassociatedlipocalinfordiagnosisofhepatorenalsyndromeinadvancedcirrhoticpatients
AT emadhamdyhamoudamohammed useofurinarykidneyinjurymolecule1andneutrophilgelatinaseassociatedlipocalinfordiagnosisofhepatorenalsyndromeinadvancedcirrhoticpatients
AT mohammedabdelgawad useofurinarykidneyinjurymolecule1andneutrophilgelatinaseassociatedlipocalinfordiagnosisofhepatorenalsyndromeinadvancedcirrhoticpatients